Use of -Blockers in Atrial Fibrillation

Author： Kühlkamp V.   Bosch R.   Mewis C.   Seipel L.  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.2, Iss.1, 2002-01, pp. : 37-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin II receptor blockers in the prevention of atrial fibrillation

By Barra Silvia   Silvestri Nunzia   Vitagliano Giancarlo   Madrid Alfredo   Gaeta Giovanni  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1395-1411

Informa Healthcare

Access to resources Recommend Favorite

Barriers to warfarin use in atrial fibrillation

By  

Inpharma, Vol. 1, Iss. 1224, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

IKur/Kv1.5 channel blockers for the treatment of atrial fibrillation

By Tamargo Juan   Caballero Ricardo   Gómez Ricardo   Delpón Eva  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 399-416

Informa Healthcare

Access to resources Recommend Favorite

Dronedarone: a guide to its use in atrial fibrillation

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 3, 2010-03 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Warfarin use suboptimal in new-onset atrial fibrillation

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 427, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite